Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer

International Journal of Clinical Oncology

Volumn 14, Issue 6, 2009, Pages 507-512

  Harada, Hideyuki ^a   Yamamoto, Nobuyuki ^a   Takahashi, Toshiaki ^a   Endo, Masahiro ^a   Murakami, Haruyasu ^a   Tsuya, Asuka ^a   Nakamura, Yukiko ^a   Ono, Akira ^a   Igawa, Satoshi ^a   Shukuya, Takehito ^a   Tamiya, Akihiro ^a   Nishimura, Tetsuo ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Concurrent chemoradiotherapy; Lung cancer; Stage III

Indexed keywords

CARBOPLATIN; CISPLATIN; IRINOTECAN; MITOMYCIN C; NAVELBINE; PACLITAXEL; VINDESINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS DISEASE; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTOPENIA; HUMAN; INFECTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 72949103987     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0907-2     Document Type: Article

References (21)

1. A. Spira D.S. Ettinger 2004 Multidisciplinary management of lung cancer N Engl J Med 350 379 392 10.1056/NEJMra035536 1:CAS:528:DC%2BD2cXmtlaksA%3D%3D 14736930 (Pubitemid 38101633)
2. D.G. Pfister D.H. Johnson C.G. Azzoli, et al. 2004 American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 330 353 10.1200/JCO.2004.09.053 14691125 (Pubitemid 41095099)
3. R.O. Dillman J. Herndon S.L. Seagren, et al. 1996 Improved survival in stage III non-small-cell lung cancer: 7-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1210 1215 10.1093/jnci/88.17. 1210 1:STN:280:DyaK28znsVeguw%3D%3D 8780630
4. W. Sause P. Kolesar S. Taylor IV, et al. 2000 Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 358 364 10.1378/chest.117.2.358 1:STN:280: DC%2BD3c7jsFOrtA%3D%3D 10669675
5. B. Jeremic Y. Shibamoto L. Acimovic, et al. 1995 Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer J Clin Oncol 13 452 458 1:STN:280:DyaK2M7kslSgsA%3D%3D 7844608
6. K. Furuse M. Fukuoka M. Kawahara, et al. 1999 Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 2692 2699 1:CAS:528:DyaK1MXmtlWru74%3D 10561343
7. W. Curran C. Scott R. Langer, et al. 2003 Phase III comparison of sequential vs concurrent chemoradiotherapy for pts with unresected stage III non-small cell lung cancer (NSCLC): report of Radiation Therapy Oncology Group (RTOG) 9410 (abstract) Proc Am Soc Clin Oncol 22 2499
8. P.A. Bunn Jr K. Kelly 1998 New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions Clin Cancer Res 4 1087 1100 1:CAS:528:DyaK1cXjt1yiur8%3D 9607565
9. P.C. Hoffman A.M. Mauer E.E. Vokes 2000 Lung cancer Lancet 355 479 485 1:STN:280:DC%2BD3c3pslygug%3D%3D 10841143
10. K. Kubota K. Watanabe H. Kunitoh, et al. 2004 Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese Taxotere Lung Cancer Study Group J Clin Oncol 22 254 61 10.1200/JCO.2004.06.114 1:CAS:528: DC%2BD2cXpsVKit7k%3D 14722033 (Pubitemid 41095089)
11. T. Le Chevalier D. Brisgand J.Y. Douillard, et al. 1994 Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 621 patients J Clin Oncol 12 360 367 8113844
12. Y. Chen P. Okunieff 2004 Radiation and third-generation chemotherapy Hematol Oncol Clin North Am 18 55 80 10.1016/S0889-8588(03)00145-X 15005281 (Pubitemid 38201549)
13. C.P. Belani H. Choy P. Bonomi, et al. 2005 Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol J Clin Oncol 23 5883 5891 10.1200/JCO.2005.55.405 1:CAS:528:DC%2BD2MXhtVKgtbzM 16087941 (Pubitemid 46300204)
14. E.E. Vokes J.E. Herndon II M.J. Kelley, et al. 2007 Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: cancer and leukemia group B J Clin Oncol 13 1698 1704 10.1200/JCO.2006.07.3569 (Pubitemid 46797950)
15. Hanna NH, Neubauer M, Ansari R, et al. (2007) Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023 (abstract) Proc Am Soc Clin Oncol 387s
16. P. Therasse S.G. Arbuck E.A. Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
17. W. Curran C. Scott C.J. Langer, et al. 2000 Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer: initial report of RTOG 9410 (abstract) Proc Am Soc Clin Oncol 19 484a
18. T. Kimura H. Uejima M. Satouchi, et al. 2007 Randomized, phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small cell lung cancer (NSCLC) (abstract) Proc Am Soc Clin Oncol 25 7530
19. K. Kiura N. Takigawa Y. Segawa, et al. 2008 Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007 (abstract) Proc Am Soc Clin Oncol 26 7515
20. C.R. Geard J.M. Jones 1994 Radiation and taxol effects on synchronized human cervical carcinoma cells Int J Radiat Oncol Biol Phys 29 565 569 1:CAS:528:DyaK2cXls12qtbo%3D 7911795
21. C.A. Perez K. Stanley P. Rubin, et al. 1980 A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung: preliminary report by the Radiation Therapy Oncology Group Cancer 45 2744 2753 10.1002/1097-0142(19800601) 45:11<2744::AID-CNCR2820451108>3.0.CO;2-U 1:STN:280:DyaL3c7pvFKrsg%3D%3D 6991092